Haylen Reytor Camps
Primary Care · Hialeah, FLNPI 1447975289
Payments from drug & device makers
Across 182 payments — averaging $18.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$510
- Sumitomo Pharma America, Inc.$364
- Amneal Pharmaceuticals LLC$321
- Amgen$316
- GSK$253
- Exact Sciences$218
- plus $1K from 16 others
What the payments were for
- Food & beverage$3,33697%
- Education$943%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 32 | $510 |
| Sumitomo Pharma America, Inc. | 16 | $364 |
| Amneal Pharmaceuticals LLC | 18 | $321 |
| Amgen | 19 | $316 |
| GSK | 14 | $253 |
| Exact Sciences | 10 | $218 |
| AstraZeneca | 10 | $216 |
| Astellas Pharma US Inc | 6 | $189 |
| Novo Nordisk | 10 | $180 |
| AbbVie | 8 | $136 |
| Johnson & Johnson | 8 | $135 |
| Bayer | 5 | $126 |
| Novartis | 6 | $111 |
| Kowa Pharmaceuticals America, Inc. | 6 | $110 |
| Boehringer Ingelheim | 4 | $77 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $50 |
| Esperion Therapeutics, Inc. | 2 | $35 |
| Amarin Pharma, Inc. | 1 | $19 |
| Abbott | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
| Heartflow, Inc. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$3,430 in reported general payments places this provider in the 90th percentile of 725 primary care providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TradjentaLinagliptin | 30 | $32,839 |
| MounjaroTirzepatide | 16 | $30,410 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $24,405 |
| JardianceEmpagliflozin | 11 | $17,844 |
| EliquisApixaban | 14 | $16,259 |
| OzempicSemaglutide | 11 | $12,443 |
| SynthroidLevothyroxine Sodium | 32 | $4,003 |
| Diclofenac Sodium | 42 | $2,776 |
| Fluticasone Propionate | 44 | $1,075 |
| Famotidine | 47 | $796 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 21 | $775 |
| Gabapentin | 47 | $692 |
| Ketoconazole | 25 | $635 |
| Atorvastatin Calcium | 103 | $591 |
| Mupirocin | 32 | $475 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimTradjenta, Jardiance | $77 | $50,68341 claims |
| Lilly USA, LLCMounjaro | $510 | $30,41016 claims |
| GSKTrelegy Ellipta | $253 | $24,40513 claims |
| Novo NordiskOzempic | $180 | $12,44311 claims |
| AbbVieSynthroid | $136 | $4,00332 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $321 | $24240 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 725 primary care providers in Florida.
Other primary care in Hialeah
- Maria Rodriguez ReyesHialeah$31K
- Paul ChanOrlando$447K
- Jenny WestPensacola$80K
- Railet RodriguezAltamonte Springs$14K
- Kevin HanawayFort Lauderdale$12K
- Kelly ChewningAlachua$11K
- Yolanda PalmeroSaint Cloud$11K
- Erica ClarkCitrus Springs$11K
- Michelle SelvaggiLakewood Ranch$10K
- Kristen DeasonTallahassee$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.